-
DISABILITY AND ADHERENCE TO GLP-1 RECEPTOR AGONISTS AND SGLT2 INHIBITORS AMONG U.S. ADULTS WITH DIABETES: EVIDENCE FROM THE MEDICAL EXPENDITURE PANEL SURVEY
Mar 18, 2026, 21:38 PM -
CAREGIVER PRODUCTIVITY LOSS AND HEALTH-RELATED QUALITY OF LIFE ASSOCIATED WITH PEDIATRIC RESPIRATORY SYNCYTIAL VIRUS INFECTION IN KOREA
Mar 18, 2026, 21:38 PM -
MEASURING ADHERENCE TO, AND PERSISTENCE WITH, ADVANCED THERAPY IN PATIENTS WITH LUPUS NEPHRITIS IN THE REAL-WORLD SETTING
Mar 18, 2026, 21:38 PM -
UNDERSTANDING THE HEALTH-RELATED QUALITY OF LIFE BURDEN IN CHRONIC HEPATITIS DELTA INFECTION: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
COST OF CARE AND BUDGET IMPACT OF FIRST-LINE (1L) TREATMENTS IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (LA/MUC) FROM THE MEXICAN PUBLIC PAYER PERSPECTIVE
Mar 18, 2026, 21:38 PM -
NATURAL HISTORY, MANAGEMENT, AND BURDEN OF DISEASE IN ADULTS WITH NF1 AND SYMPTOMATIC INOPERABLE PLEXIFORM NEUROFIBROMA IN FRANCE
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF ELRANATAMAB VERSUS PHYSICIAN’S CHOICE OF TREATMENT FOR TRIPLE-CLASS-EXPOSED MULTIPLE MYELOMA IN JAPAN
Mar 18, 2026, 21:38 PM -
COMPARATIVE ANALYSIS OF GENE THERAPIES AUTHORIZED BY THE U.S. FOOD AND DRUG ADMINISTRATION AND THE EUROPEAN MEDICINES AGENCY
Mar 18, 2026, 21:38 PM -
IMPACT OF MEDICATION CLUSTERS ON POST-DISCHARGE ADVERSE DRUG EVENTS AND HEALTHCARE UTILIZATION AMONG OLDER ADULTS
Mar 18, 2026, 21:38 PM -
PREDICTING PROSTATE CANCER INCIDENCE USING A LARGE, NATIONAL U.S. ELECTRONIC HEALTH RECORDS (EHR) DATABASE
Mar 18, 2026, 21:38 PM -
EPIDEMIOLOGY AND TREATMENT PATTERNS OF THRYOID EYE DISEASE IN SPAIN: POPULATION-BASED REAL-WORLD EVIDENCE
Mar 18, 2026, 21:38 PM -
TRANSPARENCY OF CHARLSON COMORBIDITY INDEX (CCI) CODE DEFINITIONS IN REAL-WORLD RESEARCH: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
A COST-UTILITY ANALYSIS OF TOCILIZUMAB PLUS METHOTREXATE VERSUS METHOTREXATE ALONEIN RHEUMATOID ARTHRITIS IN INDIA, USING THE MARKOV STATE TRANSITION MODEL
Mar 18, 2026, 21:38 PM -
IMPACT OF COMORBIDITIES ON SELF-REPORTED QUALITY-OF-LIFE IN US ADULTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A POOLED ANALYSIS OF THE 2016-2022 MEDICAL EXPENDITURE PANEL SURVEY (MEPS)
Mar 18, 2026, 21:38 PM -
CYP2D6-GUIDED OPIOID PRESCRIBING AND CLINICAL OUTCOMES IN CHRONIC PAIN: EVIDENCE FROM THE ADOPT PGX TRIAL LINKED TO MEDICARE AND MEDICAID CLAIMS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SILVER-CONTAINING DRESSING IN PATIENTS WITH DIABETIC FOOT ULCERS IN KOREA
Mar 18, 2026, 21:38 PM -
DO DISPARITIES IN SURGICAL REFERRALS INDICATE PREJUDICE? EVIDENCE FROM A PHYSICIAN SITUATIONAL CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM -
SOCIAL MEDIA CONVERSATIONS ON IMMUNE CHECKPOINT INHIBITORS: TREATMENT EXPERIENCES, SAFETY, ACCESS, AND PATIENT PERSPECTIVES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SINGLE-DOSE HPV VACCINATION IN NEPAL:AN ECONOMIC EVALUATION
Mar 18, 2026, 21:38 PM -
VALUE SETS FOR AQOL, EQ-5D, HUI, QWB AND SF-6D: A SYSTEMATIC REVIEW OF THEIR AVAILABILITY AND CHARACTERISTICS
Mar 18, 2026, 21:38 PM
